✦ LIBER ✦
Ki67 expression in the primary tumor predicts for clinical benefit and time to progression on first-line endocrine therapy in estrogen receptor-positive metastatic breast cancer
✍ Scribed by Y. Delpech, Y. Wu, K. R. Hess, L. Hsu, M. Ayers, R. Natowicz, C. Coutant, R. Rouzier, E. Barranger, G. N. Hortobagyi, D. Mauro, L. Pusztai
- Book ID
- 118796701
- Publisher
- Springer US
- Year
- 2012
- Tongue
- English
- Weight
- 357 KB
- Volume
- 135
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.